Arcturus Therapeutics and Cystic Fibrosis Foundation Extend Agreement to Advance ARCT-032, an Investigational Messenger RNA (mRNA) Therapeutic to Treat Cystic Fibrosis September 26, 2023https://www.businesswire.com/news/home/20230926244002/en/Arcturus-Therapeutics-and-Cystic-Fibrosis-Foundation-Extend-Agreement-to-Advance-ARCT-032-an-Investigational-Messenger-RNA-mRNA-Therapeutic-to-Treat-Cystic-Fibrosis
SpliSense Successfully Completed Phase 1 Study of SPL84, RNA-Based Therapy, for the Treatment of Cystic Fibrosis September 6, 2023https://www.prnewswire.com/news-releases/splisense-successfully-completed-phase-1-study-of-spl84-rna-based-therapy-for-the-treatment-of-cystic-fibrosis-301918897.html
BU Researchers See Future Where Lung Disease Is Treatable, and Damaged Lungs are Regenerated August 31, 2023https://www.bu.edu/articles/2023/stem-cell-therapy-lung-health-and-disease/
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection August 29, 2023https://classic.clinicaltrials.gov/ct2/show/NCT06016088
Novel Approach Developed for Engrafting Engineered Cells Into Injured Lung Tissue August 29, 2023https://www.technologynetworks.com/cell-science/news/novel-approach-developed-for-engrafting-engineered-cells-into-injured-lung-tissue-378209
Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis (ABCI) August 23, 2023https://classic.clinicaltrials.gov/ct2/show/NCT05802264
Porosome Therapeutics, Inc. Files Comprehensive Patent for New Generation of Treatments for Cystic Fibrosis and Other Diseases August 21, 2023https://www.porosome.com/news/porosome-therapeutics-inc-files-comprehensive-patent-for-new-generation-of-treatments-for-cystic-fibrosis-and-other-diseases
Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection August 14, 2023https://classic.clinicaltrials.gov/ct2/show/NCT05010577
A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis August 11, 2023https://www.sciencedirect.com/science/article/abs/pii/S1526054223000453
FDA Grants BiomX’s BX004 Clinical Program in Cystic Fibrosis Fast Track Designation August 9, 2023https://www.globenewswire.com/news-release/2023/08/09/2721423/0/en/BiomX-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
This fish delivers a nasty sting. Could it also save lives? July 24, 2023https://www.science.org/content/article/fish-delivers-nasty-sting-could-it-also-save-lives
Safety, Tolerability, and Pharmacokinetics of ARCT-032 in Healthy Adult Subjects April 7, 2023https://classic.clinicaltrials.gov/ct2/show/NCT05712538
